कोशिश गोल्ड - मुक्त
AstraZeneca to bring innovative drugs faster to India: MD
Mint Chennai
|March 06, 2025
AstraZeneca India has seen its profit and revenue jump in the past year, driven by a robust product portfolio focused on cancer and non-communicable diseases.
The drugmaker's British-Swedish parent has already received approvals for 14 products over the past two years, and aims to expedite more launches to bolster its business in India, a top company official said.
"Our first strategy is to bring innovative medicine faster into the country, which otherwise [patients] would go to other parts of the developed world to buy," Sanjeev Panchal, managing director of AstraZeneca India, told Mint in an interview.
यह कहानी Mint Chennai के March 06, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Chennai से और कहानियाँ
Mint Chennai
Small-town wealthy dive into high-risk PMS schemes
Sophisticated, high-risk investments are no longer confined to the rich in metropolitan cities.
1 min
December 04, 2025
Mint Chennai
‘Targeting public debt appropriate during uncertainty’
India’s shift from targeting annual fiscal deficit to long-term debt was appropriate during a period of external economic uncertainty, chief economic adviser V. Anantha Nageswaran said.
1 mins
December 04, 2025
Mint Chennai
Services PMI rebounds in November
India’s services sector rebounded in November, as new business intakes increased amid subdued price pressures and improving demand, a private sw showed on Wednesday.
2 mins
December 04, 2025
Mint Chennai
Climate chaos: Megacities face rapidly rising risks of flooding
Urban spaces in the tropical monsoon belt are the most vulnerable
3 mins
December 04, 2025
Mint Chennai
Seeking affordable financial advice? Try fixed-fee RIAs
Sebi-registered RIAs earn from client fees, not commissions, ensuring conflict-free guidance
5 mins
December 04, 2025
Mint Chennai
IT sector sheds weight in stock market indices as AI rises
Since the start of the year, shares of the five largest firms have seen sharp drops: TCS fell by 23.47%, Infosys 17%, HCLTech 14.74%, Wipro 17.14%, and Tech Mahindra 9.97%.
2 mins
December 04, 2025
Mint Chennai
IT sheds weight in indices as AI rises
Combined weight of IT cos in BSE Sensex down to 18-year low
1 mins
December 04, 2025
Mint Chennai
JLR CEO Balaji's early trials: top exit, cyberattack impact
Gerry McGovern's abrupt removal has created uncertainty over brand and design strategy
3 mins
December 04, 2025
Mint Chennai
IndiGo flights hit by pilot rest rules, weather, leaves
DGCA probing disruption, working with IndiGo to minimize inconvenience
2 mins
December 04, 2025
Mint Chennai
Natco Pharma's cyclical model leaves revenue outlook cloudy
Shares of Natco Pharma Ltd have dropped 38% from the 52-week high of ₹1,505 (December 2024), as the Street grows cautious about its high-risk, high-reward business model.
1 mins
December 04, 2025
Listen
Translate
Change font size